Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model

Fig. 4

Projected incremental epidemiological impact of decentralized versus centralized Xpert testing for tuberculosis (TB). Panels compare the impact of Xpert implemented via a decentralized strategy compared to centralized testing, in terms of the cumulative number of DS-TB infections averted (a), cumulative number of drug-resistant (DR) TB infections averted (b), and cumulative number of TB deaths averted (c). All values are adjusted to a population size of 100,000. Shaded areas and arrows represent interquartile uncertainty ranges

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us